Canada Markets closed
  • S&P/TSX

    17,909.03
    -49.06 (-0.27%)
     
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • DOW

    30,814.26
    -177.26 (-0.57%)
     
  • CAD/USD

    0.7853
    -0.0024 (-0.3015%)
     
  • CRUDE OIL

    52.04
    -1.53 (-2.86%)
     
  • BTC-CAD

    46,126.35
    -1,731.21 (-3.62%)
     
  • CMC Crypto 200

    693.09
    -42.05 (-5.72%)
     
  • GOLD FUTURES

    1,827.70
    -23.70 (-1.28%)
     
  • RUSSELL 2000

    2,123.20
    -32.15 (-1.49%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • NASDAQ

    12,998.50
    -114.14 (-0.87%)
     
  • VOLATILITY

    24.34
    +1.09 (+4.69%)
     
  • FTSE

    6,735.71
    -66.25 (-0.97%)
     
  • NIKKEI 225

    28,519.18
    -179.08 (-0.62%)
     
  • CAD/EUR

    0.6499
    +0.0024 (+0.37%)
     

Roche extends offer deadline for Spark Therapeutics again

FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

ZURICH (Reuters) - Roche <ROG.S> has again extended the deadline for its tender offer for Spark Therapeutics <ONCE.O>, the Swiss drugmaker said on Friday, saying U.S. and British anti-trust authorities needed more time to review the deal.

The offer, which was originally due to expire on Nov. 25, has now been extended to Dec. 10. All terms and conditions of the offer remain the same, Roche said. So far 14.8% of the shares were tendered.

Roche has put back the deadline several times since it announced the $4.3 billion offer to buy the gene therapy company in February.

(Reporting by John Revill; Editing by Michael Shields)